SOURCE: Rx Processing Corp

May 10, 2006 10:04 ET

Rx Processing Corp. Announces Agreement Resolving Past Litigation

WILMINGTON, DE -- (MARKET WIRE) -- May 10, 2006 -- Rx Processing Corporation (OTC: RXPC), a source of low-cost prescription medications and diagnostic laboratory tests for millions of Americans who are under-insured or have no prescription insurance coverage, is actively finalizing a stipulated final judgment to amicably resolve pending litigation filed against George Donnelly and D&M Enterprises in April 2005.

Rx Processing Corp and George Donnelly are prevailing peacefully in negotiating the ending of a suit filed in 2005, contesting previous actions while acting as Chief Operating Officer of Rx processing Corp. Our collective action signals a common message to shareholder's that disagreeing parties can co-exist as allies rather than adversaries in servicing clients in this emerging market. In our on-going mission, RXPC continues to enhance the distribution and sourcing of prescription medications and laboratory testing to all clients. The building of team relationships and redundant networks continues to serve the under and uninsured while peacefully furthering the mission of achieving affordable health care. Through the establishment of a non-contested corporation, owned by George Donnelly we can collectively strive towards achievement of a common goal.

Peter Fiorillo stated, "Protecting shareholder value and continuing the pursuit of making health care more affordable to the under and uninsured is job one. Rx Processing Corp will be receiving back 5,000,000 shares of RXPC common stock originally issued. George Donnelly will move forward with D&M Enterprises Inc. the public will gain two strong independent groups working daily to service the health care needs of our citizens."

"Rx processing Corp anticipates the stipulated final judgment closing by June 15th, 2006."

http://www.rxprocessingcorp.com

About Rx Processing

Rx Processing is positioned to become a market leader in providing prescription medications and preventive health laboratory tests to U.S. citizens, corporations, and members, through CLIA-certified patient service centers, for their lab testing and licensed pharmacies in the United States and around the world. The company provides access to approved brand-name and generic medications, and hundreds of lab tests with access to 4,000+ CLIA-certified patient service centers for their lab testing. Rx Processing Corp. estimates that more than 44 million United States Citizens could benefit from the company's affordable prescription medication and laboratory testing programs.

Safe Harbor Statement

All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the company and factors that are subject to uncertainties, risk and other influences, which are outside the company's control, and may yield results differing materially from those anticipated. Rx Processing Corp is working diligently to have the stipulated final judgment. signed in a 'Language' which Peter Fiorillo and George Donnelly negotiated during telephone conversations over the past six weeks. Rx Processing Corp reserves the right not to execute or sign the stipulated final judgment.

Contact Information